Hi Quip
Firstly, links are below to three previous posts on Soleno.
Yes Soleno’s market cap increased dramatically in September this year (it has gone from US$44m to US$1.2 bn) because its second Phase 3 trial met its primary endpoint and Soleno is now preparing to submit an NDA to the FDA.
Like Acadia’s trial, the focus is on hyperphagia associated with Prader-Willi syndrome.
We won’t see a 2000% rise when our PWS results come out because it is Phase 2 only, not a registrational trial, and because our market cap is already well advanced from $44m!
Our orphan drug status remains – there can be multiple orphan drugs for the same indication. Orphan drug status protects you from generic competition for 7 years but not from competition from other drugs.
https://hotcopper.com.au/threads/phase2-prader-willi-syndrome-start.7407217/page-16?post_id=70059494
https://hotcopper.com.au/threads/phase2-prader-willi-syndrome-start.7407217/page-15?post_id=70052057
https://hotcopper.com.au/threads/share-price.6359591/page-640?post_id=58554923
- Forums
- ASX - By Stock
- NEU
- Neuren Media and Analyst Coverage
Neuren Media and Analyst Coverage, page-640
-
- There are more pages in this discussion • 667 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$15.57 |
Change
-0.040(0.26%) |
Mkt cap ! $1.990B |
Open | High | Low | Value | Volume |
$15.83 | $15.87 | $15.20 | $8.124M | 524.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 64 | $15.49 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.58 | 597 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 64 | 15.490 |
2 | 1474 | 15.480 |
1 | 8454 | 15.460 |
1 | 1808 | 15.440 |
2 | 2028 | 15.400 |
Price($) | Vol. | No. |
---|---|---|
15.580 | 597 | 1 |
15.590 | 1867 | 2 |
15.600 | 602 | 2 |
15.610 | 506 | 1 |
15.620 | 1108 | 1 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |